Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-04-14

Clinical Trial Update: B-PaLMZ for TB Meningitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of B-PaLMZ for tuberculous meningitis is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • B-PaLMZ

Snippet

Sponsor: University of Minnesota | Conditions: Tuberculous Meningitis | Phase 2 | Status: NOT_YET_RECRUITING